Skip to content

The effect of iTBS mode repetitive transcranial magnetic stimulation combined with isokinetic muscle strength training on upper limb function in patients with spinal cord injury

The effect of iTBS mode repetitive transcranial magnetic stimulation combined with isokinetic muscle strength training on upper limb function in patients with spinal cord injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103234
Enrollment
Unknown
Registered
2025-05-27
Start date
2025-06-09
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cord injury

Interventions

Group A:Group A patients received iTBS stimulation therapy on the basis of routine rehabilitation treatment.
Group B:Group B patients were given isokinetic muscle strength training on the basis of routine rehabilitation treatment.
Group C:Group C received isokinetic muscle strength training combined with iTBS stimulation therapy on the basis of routine rehabilitation treatment.

Sponsors

China Rehabilitation Research Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Meets the evaluation criteria of the International Classification of Spinal Cord Injury Neurology (revised in 2021) and is confirmed by medical history and imaging examinations to have spinal cord injury; 2) Incomplete spinal cord injury (AISAC or D) involving the cervical spine (C4, C5, C6, C7); 3) Improved Ashworth Scale (MAS)= 21 on the Mini Mental State Examination (MMSE).

Exclusion criteria

Exclusion criteria: 1) Individuals with fractures, severely restricted joint mobility, deformities, or amputations; 2) SCI caused by multiple sclerosis, spinal cord hemangioma, or spinal cord tumor; 3) Contraindications for TMS, such as patients implanted with pacemakers, deep brain stimulators, Baclofen pumps, or any ferromagnetic metal implants near the target stimulation area, or those who lack tolerance to TMS and have skull defects; Accompanied by neurological disorders, including any history of epilepsy and polyneuropathy; 4) Individuals with active infectious diseases such as pulmonary tuberculosis, severe cardiovascular and cerebrovascular diseases, and liver and kidney dysfunction; 5) Patients with severe cognitive impairment; 6) Pregnant women.

Design outcomes

Primary

MeasureTime frame
Spinal cord independence assessment scale (SCIM-III);Latency and amplitude of motor evoked potential (MEP);

Secondary

MeasureTime frame
Joint range of motion;Muscle Strength;Upper Limb Function Questionnaire (CUE-Q);tonicity of muscles;Functional Near Infrared Spectroscopy (fNIRS);

Countries

China

Contacts

Public ContactJunming Liu

China Rehabilitation Research Center,Beijing Boai Hospital

LJ1052633800@163.com+86 135 2297 7296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026